瑞宁-血管酶系统在糖尿病病中的作用:最新情况
Andre Sanglard1, Barbara Castello Branco Miranda1, Ana Luiza França Vieira1
1Interdisciplinary Laboratory of Medical Investigation, Unit of Pediatric Nephrology, Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
糖尿病脏病 (DN) 涉及氨酸-血管素系统 (RAS). 准ACE2-Ang-(1-7)-Mas轴为治疗糖尿病损伤提供了新的希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病病 (DN) 是末期病 (ESRD) 的主要原因之一.
- 氨酸-血管氨系统 (RAS) 在DN病变发生过程中发挥着关键作用.
- 了解RAS调制是开发有效DN治疗的关键.
研究的目的:
- 审查氨酸- ангиотензин系统 (RAS) 在糖尿病病 (DN) 中的作用.
- 突出目前针对DN的RAS的治疗方法.
- 探索DN管理的新兴治疗视角.
主要方法:
- 进行了到2024年3月的叙事文献综述.
- 在Scopus,PubMed,Scielo和Cochrane数据库中进行了搜索.
- 专注于经典和替代RAS轴和DN的新疗法方法.
主要成果:
- 经典的RAS轴 (ACE,Ang II,AT1受体) 通过血管收缩和纤维化加剧了DN.
- 目前的治疗方法 (ACE抑制剂,ARBs) 通过阻断经典轴来减缓DN进展.
- 替代的ACE2-Ang-(1-7)-Mas轴显示出脏保护作用,抵消Ang II.
- 像SGLT2抑制剂这样的新兴疗法也有利于DN患者.
结论:
- ACE 抑制剂,ARB 和 SGLT2 抑制剂是当前 DN 的支柱.
- ACE2-Ang-(1-7)-Mas轴代表了DNA的一个有前途的治疗点.
- 将替代RAS轴的临床前发现转化为临床实践对于未来的DN治疗改进至关重要.
更多相关视频
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hormonal Regulation
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
